Cost-effectiveness of long-acting injectable cabotegravir-rilpivirine as HIV treatment per virally-suppressed persons in a San Francisco clinic: an intermediary outcome analysis

Marseille, E., Walker, R. S., Hickey, M. D., Grochowski, J., Mayorga-Munoz, F., Oskarsson, J., Imbert, E., Shiels, M., Szumowski, J. D., Neilands, T. B., Johnson, M. O., Gandhi, M., & Christopoulos, K. A. (2025). Cost-effectiveness of long-acting injectable cabotegravir-rilpivirine as HIV treatment per virally-suppressed persons in a San Francisco clinic: an intermediary outcome analysis. AIDS. https://doi.org/10.1097/qad.0000000000004145

Authors:

Elliot Marseille

Ryan S Walker

Matthew D Hickey

Janet Grochowski

Francis Mayorga-Munoz

Jon Oskarsson

Elizabeth Imbert

Mary Shiels

John D Szumowski

Tor B Neilands

Mallory O Johnson